http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021204517-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_988122f414e42e549600588bea6f9f3f |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-02 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 |
| filingDate | 2021-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa875e38dc7f52df2650bd4541428db5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08b141426d1e6492134bbb178f50d57e |
| publicationDate | 2021-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2021204517-A1 |
| titleOfInvention | Composition for use in preventing atherosclerosis developpment |
| abstract | Composition for use in a method of protecting mammalian subjects against atherosclerosis development, in particular against atheroma formation or in atheroma reduction, by oral administration of an aqueous liquid extract of spirulina including phycocyanin. Said composition can be used in a method of protecting genetically hypercholestolemic mammalian subjects against atherosclerosis development. Moreover, said composition can be used especially for protecting offspring mammalian subjects against atherosclerosis development, by oral administration to mothers of the offspring subjects of said composition at least during a part of the gestation period of the offspring mother or at least during part of the gestation period and of the lactation period. |
| priorityDate | 2020-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 514.